Faricimab Molecular Design and Role of Ang-2

Opinion
Video

Panelists discuss how faricimab’s bispecific antibody design uniquely targets both VEGF-A and Ang-2 pathways, addressing the complementary role of Ang-2 in vascular destabilization and inflammation in retinal diseases.

Video content above is prompted by the following:

  • What is the unique nature of the faricimab molecule, and what is the clinical rationale for targeting Ang-2 in treating retinal diseases?
Recent Videos
2 experts in this video
3 experts are featured in this series.
2 experts in this video
2 experts in this video
2 experts in this video
3 experts are featured in this series.
3 experts are featured in this series.
2 experts in this video
2 experts in this video
2 experts in this video
Related Content
© 2025 MJH Life Sciences

All rights reserved.